Home etftrends.com Marijuana ETFs Grow after Aphria’s Sales Beat Projections

Marijuana ETFs Grow after Aphria’s Sales Beat Projections

Marijuana stocks and sector-related exchange traded funds surged Thursday after Canadian cannabis growers reported some stellar quarterly results.

Among the best performing non-leveraged ETFs of Thursday, the ETFMG Alternative Harvest ETF (NYSEArca: MJ)advanced 8.2%, Cambria Cannabis ETF (TOKE) increased 5.2%, Global X Cannabis ETF (NASDAQ: POTX) surged 10.6%, AdvisorShares Pure Cannabis ETF (YOLO) gained 4.9%, Amplify Seymour Cannabis ETF (NYSEARCA: CNBS) rose 6.6%, and The Cannabis ETF (NYSE ARCA: THCX) jumped 7.8%.

Leading the charge, Aphria (APHA) advanced 21.2% and Tilray (TLRY) was 22.0% higher.

Aphria revealed fiscal second quarter net sales of 160.5 million Canadian dollars, or $126.6 million, which was up 10% quarter-over-quarter, beating many analysts’ expectations, Investor’s Business Daily reports.

APHA 1 Year Performance

APHA 1 Year Performance

The pot grower also reported its fourth quarter results after agreeing to merge with rival Tilray, potentially creating the largest global weed industry player.

Will Marijuana Be Decriminalized Federally?

Meanwhile, there is growing speculation that the U.S. could move toward decriminalizing marijuana on the federal level as Democrats control both the White House and Congress. Only some individual states have legalized marijuana for recreational use.

However, some issued a word of caution on the deceleration in cannabis sales.

“While the headlines are positive, we believe the slowing growth from the Canadian adult use business is a concern with the outsize contribution from global medical sales (C$5.3 million) likely aiding profitability,” Stifel analyst Andrew Carter said in a research note.

Jason Wilson, Cannabis Research and Banking Expert at ETFMG, said in a note that it is expected that 2020 global cannabis sales will reach approximately $20 billion, an increase of approximately 35% when compared to 2019 sales of $15 billion.

“With several catalysts on the horizon, 2021 will likely be another banner year for the cannabis industry – adult-use legalization in Mexico and U.N. re-classification should help drive global sales; in the U.S., Democratic control of Congress and the White House is expected to result in significant policy reform,” Wilson said in a note. “Additionally, with state’s looking for ways to bolster their economies, expect to see more states move to legalize recreational use in 2021, including New York, Virginia, Connecticut, New Mexico and Maryland.”

For more news, information, and strategy, visit the Equity ETF Channel.

newETFs.io respects the hard work of others and gives all credit to the remarkable folks at ETFTrends.com. This excerpt/article was pulled from their RSS feed; click here to view the original. Please note that on occasion, the RSS feed will not have the author. When this happens this site defaults the author to "News". Make no mistake, this excerpt/article was not created by newETFs.io, it was simply shared with you.